Recent Finacing
Recent Raise
Artios uses a DDR-focused platform and small-molecule discovery to develop cancer therapies, advancing ATR inhibitor ART0380 and Polθ inhibitor ART4215 while collaborating with cancer research institutes and pharma partners.
